NCR2 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, NK-sensitive K562 CML-type cell line was killed very efficiently by the same NK cells (>80%) and thus incubation with the anti-NKp44 mAb did not show enhancement or reduction in lysis (data not shown).